PatientsVille.com Logo

HALLUCINATION and Mirtazapine

PatientsVille

HALLUCINATION Symptoms and Causes

Psychotic disorders are severe mental disorders that cause abnormal thinking and perceptions. People with psychoses lose touch with reality. Two of the main symptoms are delusions and Hallucinations. Delusions are false beliefs, such as thinking that someone is plotting against you or that the TV is sending you secret messages. Hallucinations are false perceptions, such as hearing, seeing, or feeling something that is not there.

Schizophrenia is one type of psychotic disorder. People with bipolar disorder may also have psychotic symptoms. Other problems that can cause psychosis include alcohol and some drugs, brain tumors, brain infections, and stroke.

Treatment depends on the cause of the psychosis. It might involve drugs to control symptoms and talk therapy. Hospitalization is an option for serious cases where a person might be dangerous to himself or others.

Check out the latest treatments for HALLUCINATION

HALLUCINATION treatment research studies

Mirtazapine clinical trials, surveys and public health registries


Find Drug Side Effect reports



Mirtazapine Side Effects

Completed Suicide (237)
Confusional State (206)
Hyponatraemia (180)
Depression (160)
Overdose (148)
Anxiety (147)
Fall (136)
Dizziness (130)
Agitation (130)
Condition Aggravated (123)
Somnolence (117)
Insomnia (113)
Headache (110)
Serotonin Syndrome (109)
Suicidal Ideation (107)
Fatigue (105)
Loss Of Consciousness (104)
Convulsion (103)
Aggression (103)
Suicide Attempt (100)
Nausea (96)
Oedema Peripheral (93)
Dyspnoea (92)
Weight Increased (90)
Tachycardia (90)
Tremor (84)
Malaise (82)
Vomiting (75)
Restless Legs Syndrome (75)
Myalgia (73)
Alanine Aminotransferase Increased (72)
Cardiac Arrest (71)
Inappropriate Antidiuretic Hormone Secretion (71)
Feeling Abnormal (70)
Toxicity To Various Agents (69)
Asthenia (69)
Diarrhoea (67)
Syncope (62)
Hyperhidrosis (61)
Neuroleptic Malignant Syndrome (61)
Pain In Extremity (61)
Electrocardiogram Qt Prolonged (60)
Pyrexia (59)
Aspartate Aminotransferase Increased (58)
Pulmonary Embolism (57)
Arthralgia (56)
Hypotension (56)
Irritability (56)
Pain (55)
Gait Disturbance (54)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

i have been on citalopram and amatripolineand fluxaitne i have been on 15mg of mirtazapine and tryed 30mg the doc has put me on 45mg and i asked if these tablets dont work what is next hes said shrink as i have tryed all the ones he said but i have

My symptoms were tired, weak, unable to sleep. Was prescribed half of a 15 MG Mirtazapine nightly to help me sleep. Has this drug been successful used as a sleeping aid?

The above comment is too stupid, I actually LOLed at you Pete... lol you gave it 2 days and your complaining about the side-effects? and on 15 mgs? LMAO!!! It takes couple weeks at least to cope with the side-effects; just like m

48 year old male, I have suffered depression all my life. Have used SSRI's for the last ten years with good but mixed results. Last year lost my job due to an episode where I ended up throwing my monitor across the office and have not been able to wo

After a nasty experience with citalapram i was advised by my doc to try mirtazapine and it has suitedme very well. only side effect i canreport is an appetite increase. However as i don't carry much weight that isnt a problem.&

Back pain

Been on 90mg mirtazapine for 6 years twice the recomended dose is this considered safe

Body covered in hives

Does mirtazapine have muscles side effects?

Hi, I have been on mittazapine for 10 days, sleepy , tierd all the time and slugish in response to conversation just horrid feel gastly , head ace, The worst went to bed 11pm took the 15mg pill, went to the loo at 3am and collapse

Can pantoprazole cause hallucination in elderly??

I am a five day course of elequine and since I started to take it, I have experienced dry throat, abdominal pains. insomnia, and even hallucination (really bad dreams). I hope to finish in another two(2) days, I am sticking it out, but I fe

I think this drug killed my mother. She went to ER with confusion/hallucinations. They gave her anti hallucination drug, Narcan, Morphine. She seemed to have had a stroke. Something went terribly wrong. Then she passed away 5 days later.

I was terribly ill with vertigo, violent palpitation's, nausea, insomnia, hallucination's, and breathing problems. All that from 1 tablet of the smallest dose.

My daughter was having some kind of mental illness. She was given quitiapine. In about 10 days she was given 8 mg/day. When the dose was increased to 8 mg/day she started to hear loud sounds. Before this she had no auditory hallucination. Till now sh

My mum, 80 years old, had Urinary Tract Infection. Prescribed 7 days of Invanz Injection. After the 4th Injection, she experienced the following side effects : 'hallucination', insomnia, leg weakness, mental stage change, seeing things and people tha

HALLUCINATION Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Transcranial Current Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder;   Auditory Hallucinations
Interventions: Device: tDCS;   Device: tACS;   Device: Sham stimulation
Outcome Measures: Change in Auditory Hallucination Rating Scale (AHRS)score from baseline to day 5;   Persistence of decrease in AHRS score over time
2 Recruiting Multimodal MRI-guided rTMS to Treat Refractory Hallucinations
Conditions: Hallucinations;   Schizophrenia;   Perceptual Disorders
Intervention: Device: MagPro X100 repetitive Transcranial Magnetic Stimulation
Outcome Measures: Severity and Frequency of Hallucinations;   Clinical State;   MRI changes
3 Recruiting Understanding Hallucinations (Part I)
Conditions: Hallucinations;   No Hallucinations
Intervention:
Outcome Measures: The number of clusters of patients with shared symptom profiles as determined by latent class analysis, and the difference in scores on cognitive assessment between these identified clusters.;   The internal consistency, test-retest reliability, inter-rater reliability, criterion validity and construct validity of a newly developed questionnaire.;   The difference in scores on cognitive assessment between participant groups with and without psychotic symptoms.
4 Recruiting Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations
Condition: Schizophrenia
Interventions: Device: Magstim Rapid 2 system triggering Magstim Super Rapid system;   Device: Magstim Rapid-2 system triggering Magstim Super Rapid system
Outcome Measures: Hallucination change score;   Clinical Global Improvement Scale;   Frequency subscale of Auditory Hallucinations Rating Scale;   Summed scores of Auditory Hallucination Rating Scale;   PANSS composite positive symptoms scale;   PANSS composite negative symptom scale;   PANSS total score;   California Verbal Learning Test (CVLT)
5 Recruiting Transcranial Direct Current Stimulation (tDCS) and Hallucinations in Schizophrenia
Conditions: Schizophrenia;   Auditory Hallucinations
Interventions: Procedure: direct current stimulation over brain areas;   Procedure: direct current stimulation (sham)
Outcome Measures: Auditory Hallucinations measured by Auditory Hallucination Rating Scale (Hoffman et al., 2003);   Neurochemical impact of treatment measured by 1H-MRS, DTI and resting MRI
6 Recruiting Theta Burst Transcranial Magnetic Stimulation as Treatment for Auditory Verbal Hallucinations
Conditions: Schizophrenia;   Psychotic Disorders
Intervention: Other: Theta Burst Transcranial Magnetic Stimulation
Outcome Measures: Change in severity and frequency of auditory verbal Hallucinations;   Number and severity of adverse events
7 Recruiting Non-invasive Brain Stimulation for Auditory Verbal Hallucinations in Schizophrenia
Conditions: Auditory Verbal Hallucinations;   Schizophrenia
Intervention: Device: tDCS
Outcome Measures: Change of Auditory Hallucination Rating Scale score;   Positive And Negative Syndrome Scale
8 Not yet recruiting Transcranial Direct Current Stimulation as Treatment for Auditory Hallucinations
Conditions: Psychotic Disorders;   Mood Disorders;   Personality Disorders;   Stress Disorders, Post-Traumatic;   Hearing Disorders
Interventions: Device: Eldith DC Stimulator stimulation;   Device: Eldith DC Stimulator sham stimulation
Outcome Measures: Total score of the Auditory Hallucination Rating Scale (AHRS) questionnaire;   Changes in severity of Hallucinations as assessed by the Hallucination change scale (HCS)questionnaire;   Changes of positive, negative and disorganized symptomatology as assessed by the positive and negative syndrome scale (PANSS);   Severity of psychotic symptoms will be measured by the questionnaire for psychotic symptoms (QPS);   Prior expectations regarding the efficacy of the treatment of the participants;   Strength of the motor threshold as assessed using TMS;   The presence and severity of side-effects will be monitored using the tDCS adverse effects questionnaire
9 Not yet recruiting Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Rivastigmine
Outcome Measures: time to start with antipsychotic treatment for visual Hallucinations;   motor control;   psychotic symptoms;   cognitive function;   mood disturbance;   daytime sleepiness;   cholinergic deficiency;   adverse events;   compliance;   disability;   caregiver burden;   care use
10 Recruiting TDCS for Auditory Hallucinations in Schizophrenia
Condition: Schizophrenia
Interventions: Device: transcranial Direct Current Stimulation (tDCS);   Device: Sham tDCS
Outcome Measures: Severity of refractory auditory Hallucinations;   Severity of negative schizophrenia symptoms
11 Recruiting Magnetic Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia
Condition: Schizophrenia
Intervention: Device: Paired Pulse
Outcome Measures: Hoffman Auditory Hallucination Scale;   Positive and Negative Syndrome Scale for Schizophrenia (PANSS)
12 Recruiting Auditory Verbal Hallucinations in Schizophrenia
Condition: Schizophrenia
Intervention:
Outcome Measure: Labial EMG activity during auditory verbal Hallucination
13 Recruiting High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in Schizophrenia : a Randomized Controlled Study
Condition: Auditory Hallucinations in Patients With Schizophrenic Disorders
Interventions: Device: Transcranial magnetic stimulation: rTMS;   Device: Placebo (sham coil) treatment
Outcome Measure: The primary assessment is the percentage of patients who present a decrease of more than 30% of the frequency item of AHRS between D1 and D30 at 2 evaluations spaced of 1 week (Responder patients)
14 Unknown  Transcranial Magnetic Stimulation (TMS) in Schizophrenia
Condition: Schizophrenia
Interventions: Device: DEEP TMS H1 coil;   Device: Deep H1 coil TMS
Outcome Measures: 1.Auditory Hallucinations Rating Scale developed by Hoffman and colleagues (2003) 2.SAPS 3.CGI 4.SANS 5.GAF;   Q-LES-Q;   QIDS-SR16;   CTAHE
15 Recruiting The Prevention of Delirium and Complications Associated With Surgical Treatments Multi Center Clinical Trial
Condition: Delirium
Interventions: Drug: Ketamine (0.5 mg/kg);   Drug: Normal Saline (placebo);   Drug: Ketamine (1 mg/kg)
Outcome Measures: Delirium;   Acute pain;   Postoperative opioid consumption;   Postoperative nausea and vomiting;   ICU and/or hospital length of stay;   Adverse outcomes (e.g. Hallucinations and nightmares)
16 Recruiting Transcranial Direct Current Brain Stimulation to Treat Patients With Childhood-Onset Schizophrenia
Conditions: Childhood Onset Psychotic Disorders;   Schizophrenia;   Psychosis;   Mental Disorders Mental Disorder Diagnosed in Childhood
Intervention: Behavioral: Electrical Polarization
Outcome Measures: TDCS treatment is safe in childhood onset schizophrenia;   Improvement in cognition and psychosis
17 Recruiting Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography
Conditions: Schizoaffective Disorder;   Schizophrenia
Intervention:
Outcome Measure: Regional binding potentials of [11C]NNC-112 and [18F]Fallypride
18 Unknown  Donepezil Treatment of Psychotic Symptoms in Dementia Patients
Condition: Dementia of Alzheimer Type
Intervention: Drug: donepezil
Outcome Measures: Possitive and Negative Syndrome Scale;   Clinical Global Impression
19 Recruiting Remote Cognitive Remediation
Conditions: Schizophrenia;   Bipolar Disorder With Psychosis
Interventions: Behavioral: Cognitive Remediation;   Behavioral: Sham Cognitive Remediation
Outcome Measures: Neurocognitive composite score;   Functional Capacity
20 Not yet recruiting Preventing Post-traumatic Stress in ICU Survivors: A Pilot Randomized Controlled Trial of ICU Diaries
Conditions: Stress Disorders, Post Traumatic;   Anxiety;   Depression;   Quality of Life
Interventions: Behavioral: ICU Diary;   Behavioral: Psychoeducation
Outcome Measures: Feasibility;   Efficacy